Phase 1 Trial of Mutant proUK, M5, and Its Inhibitor, C1-inhibitor
Latest Information Update: 07 Nov 2021
At a glance
- Drugs M-5 (Primary) ; TS 01 (Primary)
- Indications Stroke; Thrombosis
- Focus Adverse reactions; First in man
- Sponsors Thrombolytic Science International
- 12 Jan 2015 Planned End Date changed from 1 Jan 2013 to 1 Dec 2015 as reported by ClinicalTrials.gov record.
- 12 Jan 2015 Planned primary completion date changed from 1 Jan 2013 to 1 Dec 2015 as reported by ClinicalTrials.gov record.
- 12 Jan 2015 Status changed from recruiting to suspended as reported by ClinicalTrials.gov record.